| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 04/15/2004 | WO2004031158A1 Indazolecarboxamide derivatives, preparation and use thereof as cdk1, cdk2 and cdk4 inhibitors |
| 04/15/2004 | WO2004031153A2 Enantioselective alkylation of tricyclic compounds |
| 04/15/2004 | WO2004031150A1 Oxoammonium salts of 1-oxy-2,2,6,6-tetramethyl-1-piperidine (tempo) and their use as oxidizing agents |
| 04/15/2004 | WO2004031145A2 Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors |
| 04/15/2004 | WO2004030637A2 Treatment of obesity and other disorders associated with excessive food intake |
| 04/15/2004 | WO2004030635A2 Vasculostatic agents and methods of use thereof |
| 04/15/2004 | WO2004030620A2 Novel tyrosine kinase inhibitors |
| 04/15/2004 | WO2004030611A2 Non-nucleoside reverse transcriptase inhibitors |
| 04/15/2004 | WO2004018436A3 Compounds derived from aryl carbamates, preparation thereof and uses of same |
| 04/15/2004 | WO2004016607B1 Inhibition of phosphoinositide 3-kinase beta |
| 04/15/2004 | WO2004014859A3 Process for preparing quinolin antibiotic intermediates |
| 04/15/2004 | WO2004009558A3 Ureido substituted benzoic acid compounds, their use for nonsense suppression and the treatment of diseases caused by such mutations |
| 04/15/2004 | WO2004005262A3 New neuropeptide y y5 receptor antagonists |
| 04/15/2004 | WO2003106381A3 Human adam-10 inhibitors |
| 04/15/2004 | WO2002083111A3 Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence |
| 04/15/2004 | US20040073054 Using a fluorinated phenyl compound containing electrophilic and nucleophilic groups |
| 04/15/2004 | US20040073039 Blocking neurotransmitter |
| 04/15/2004 | US20040073036 Substituted alkyl amido piperidines |
| 04/15/2004 | US20040073025 Thrombin inhibitors |
| 04/15/2004 | US20040072892 Dipeptidyl aminopeptidase inhibitors; kidney and liver disorders; autoimmune diseases; antiarthritic agents; psoriasis; anticancer agents |
| 04/15/2004 | US20040072889 Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia |
| 04/15/2004 | US20040072888 Administering pyrazoloanthrone compound |
| 04/15/2004 | US20040072881 Dietetics; osteoporosis; muscular disorders |
| 04/15/2004 | US20040072874 N-substituted-2-oxodihydropyridine derivatives |
| 04/15/2004 | US20040072869 Bipolar disorders; psychological diseases |
| 04/15/2004 | US20040072867 Antiemetics, antidepressants, anxiolytic agents, antitussive agents |
| 04/15/2004 | US20040072865 Anticholesterol agents; antidiabetic agents; antilipemic agents |
| 04/15/2004 | US20040072862 Compositions for treating ischemia-related neuronal damage |
| 04/15/2004 | US20040072860 Piperazin-2-one amides as inhibitors of factor xa |
| 04/15/2004 | US20040072844 2,4-Substituted indoles and methods of use |
| 04/15/2004 | US20040072843 Novel sulfonamide substituted chroman derivatives useful as beta 3 adrenoreceptor agonists |
| 04/15/2004 | US20040072830 Squalene synthetase inhibitors; antilipemic agents; antiischemic agents; cardiovascular disorders; anticholesterol agents |
| 04/15/2004 | US20040072829 Piperazinyltriazines as estrogen receptor modulators |
| 04/15/2004 | US20040072823 Central nervous system disorders; analgesics; antiinflammatory agents |
| 04/15/2004 | US20040072818 Antiinflammatory agents; autoimmune disease; anticancer agents |
| 04/15/2004 | US20040072816 Dysmenorrhea; congestive heart failure; liver disorders; vision defects |
| 04/15/2004 | US20040072802 Antiarthritic agents; antiulcer agents; bone disorders; antitumor agents; oral diseases |
| 04/15/2004 | US20040072692 4-trifluoromethylpyrazolyl-substituted pyridines and pyrimidines |
| 04/15/2004 | US20040072309 Method for producing 2-azetidinone derivative |
| 04/15/2004 | DE10257188B3 Preparation of meso-substituted cyanine dye, for radiation-sensitive coating, e.g. for making printing plate, printed circuit boards or DVD, from 2-halo-cyclo-pentene or -hexene-dianil involves 1-stage introduction of end and meso-groups |
| 04/15/2004 | DE10248067A1 New N-diaminophenylpropyl- or N-heteroarylpropyl-piperazine or piperidine derivatives, useful as dopaminergic and/or serotoninergic agents for e.g. treating Parkinson's disease or schizophrenia |
| 04/15/2004 | CA2726754A1 N-substituted-2-oxodihydropyridine derivatives |
| 04/15/2004 | CA2501292A1 Enantioselective alkylation of tricyclic compounds |
| 04/15/2004 | CA2501243A1 Piperidine derivatives as ccr5 inhibitors |
| 04/15/2004 | CA2500977A1 2-thiohydantoine derivative compounds and use thereof in therapeutics |
| 04/15/2004 | CA2500815A1 Method and intermedia used to obtain derivatives of 1-(1h-benzimidazole-2-il)-4-(2-aminopyrimidine)piperidine |
| 04/15/2004 | CA2500727A1 Vasculostatic agents and methods of use thereof |
| 04/15/2004 | CA2499732A1 Piperazine derivatives and methods of use |
| 04/15/2004 | CA2496565A1 Non-nucleoside reverse transcriptase inhibitors |
| 04/15/2004 | CA2495698A1 Imidazol-1-ylmethyl pyridazine derivatives |
| 04/14/2004 | EP1408037A1 Novel diarylmethylpiperazine and diarylmethylphenyl compounds with analgesic effect |
| 04/14/2004 | EP1407774A1 2-Amino-4-quinazolinones as LXR nuclear receptor binding compounds |
| 04/14/2004 | EP1406983A1 Tertiary diamines containing heterocyclic groups and their use in organic electroluminescent devices |
| 04/14/2004 | EP1406897A2 Compounds |
| 04/14/2004 | EP1406894A1 Piperazine oxime derivatives having nk-1 receptor antagonistic activity |
| 04/14/2004 | EP1406893A1 Pyrrolidine bicyclic compounds |
| 04/14/2004 | EP1406892A1 Phenyl pyrazole derivatives as soluble epoxide hydrolase inhibitors |
| 04/14/2004 | EP1406884A1 Arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders |
| 04/14/2004 | EP1406878A1 4-(benzylidene-amino)-3-(methylsulfanyl)-4h-(1, 2, 4) triazin-5-one derivatives having a pde-iv inhibiting and tnf-antagonistic effect for the treatment of cardiac diseases and allergies |
| 04/14/2004 | EP1406877A1 Heterocyclic amines for the treatment of conditions associated with gsk-3 |
| 04/14/2004 | EP1406875A1 N-heterocyclic inhibitors of tnf-alpha expression |
| 04/14/2004 | EP1406873A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 04/14/2004 | EP1406872A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 04/14/2004 | EP1406696A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease |
| 04/14/2004 | EP1406628A1 Tetrahydroquinoline derivatives |
| 04/14/2004 | EP1406627A1 Pyridin-2-yl-methlyamine derivatives for treating opioid dependence |
| 04/14/2004 | EP1406626A2 Sulphonyl aryl hydroxamates and their use as mmp inhibitors |
| 04/14/2004 | EP1406622A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 04/14/2004 | EP1406620A1 Vinyl phenyl derivatives as glk activators |
| 04/14/2004 | EP1406619A1 Antiviral and antimicrobial guanidine or biguanidine derivatives |
| 04/14/2004 | EP1406618A2 Use of nk-1 receptor antagonists with pyridinic structure for the treatment of brain, spinal or nerve injury |
| 04/14/2004 | EP1406602A2 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 04/14/2004 | EP1406572A2 Pediatric formulation of gatifloxacin |
| 04/14/2004 | EP1375465A9 Cyclooctanone derivative and cyclodecanone derivative, and use thereof |
| 04/14/2004 | EP1305270B1 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids |
| 04/14/2004 | EP1214312B1 5-aminoalkyl and 5-aminocarbonyl substituted indoles |
| 04/14/2004 | EP1214299B1 Muscarinic antagonists |
| 04/14/2004 | EP1155012B1 Anti-cancer dihydroquinazoline derivatives |
| 04/14/2004 | EP1131297B1 Certain substituted caprolactams, pharmaceutical compositions containing them and their use in treating tumors |
| 04/14/2004 | EP1042315B1 Cyclic imide-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents |
| 04/14/2004 | EP0948495B1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents |
| 04/14/2004 | EP0935465B1 Novel substituted imidazole compounds |
| 04/14/2004 | EP0912565B1 Process for preparing imidazoquinolinamines |
| 04/14/2004 | EP0892790B1 New quinazoline-4-amino-2-(piperidine-1-yl-4-substituted) derivatives having anti-hypertensive activity, a method for their preparation and their pharmaceutical use |
| 04/14/2004 | EP0706515B1 Intercalators having affinity for dna and methods of use |
| 04/14/2004 | CN1489591A Benzensulfonic acid indol-5-yl esters and antigonists of the 5-HT6 receptor |
| 04/14/2004 | CN1489586A Indazolyl-substituted pyrroline compounds as kinase inhibitor |
| 04/14/2004 | CN1489585A Process for producing substituted 2-(2-pyridylmethye)sulfinye-1H-benzinmidazoles |
| 04/14/2004 | CN1489584A Method for carbamoylating alcohols |
| 04/14/2004 | CN1489581A 喹唑啉酮衍生物 Quinazolinone derivatives |
| 04/14/2004 | CN1489580A Imidazole derivatives |
| 04/14/2004 | CN1145624C New Process |
| 04/14/2004 | CN1145623C Imidazole derivatives |
| 04/14/2004 | CN1145616C Novel amino-triazole compound, its preparation method and drug composition containing them |
| 04/14/2004 | CN1145612C New 1-aza-2-alkyl-6-aryl-cyclanes compound, its producing process and medical composition containing them |
| 04/14/2004 | CN1145609C Piperazine compounds and medical use thereof |
| 04/14/2004 | CN1145485C 8-chloro-6,11-dihydro-11-(4-piperidy lidene)-5H-benzo[5,6] cyclohepta [1,2,-b] pyridine oral compositions |
| 04/13/2004 | US6720351 1h-indole-2-carboxylic acid (2-(benzyl(methyl)amino) -2-oxo-1-phenylethyl)amides; triamide microsomal triglyceride transfer protein (mtp) and apolipoprotein b (apo b) inhibitors; obesity; antilipemic agents |
| 04/13/2004 | US6720344 Methods and compositions for stimulating osteoblast proliferation or treating malignant cell proliferation and methods for selecting osteoblast proliferation stimulants |
| 04/13/2004 | US6720339 Such as n-phenyl-4-oxo-6,6-dimethyl-4,5,6,7-tetrahydro-1h-indole-3-carboxamide; for diagnosis and treatment of anxiety, sleep and seizure disorders, overdose with benzodiazepine drugs, and for memory enhancement |